{"id":720,"date":"2025-10-28T14:00:50","date_gmt":"2025-10-28T14:00:50","guid":{"rendered":"https:\/\/wickedsister.evit.com.au\/index.php\/2025\/10\/28\/bionxts-bnt23001-for-ms-enters-final-animal-test-before-human-trials\/"},"modified":"2025-10-28T14:00:50","modified_gmt":"2025-10-28T14:00:50","slug":"bionxts-bnt23001-for-ms-enters-final-animal-test-before-human-trials","status":"publish","type":"post","link":"https:\/\/wickedsister.evit.com.au\/index.php\/2025\/10\/28\/bionxts-bnt23001-for-ms-enters-final-animal-test-before-human-trials\/","title":{"rendered":"BioNxt\u2019s BNT23001 for MS enters final animal test before human trials"},"content":{"rendered":"<p><a href=\"https:\/\/multiplesclerosisnewstoday.com\/news-posts\/2025\/10\/28\/bnt23001-ms-enters-final-animal-test-human-trials\/\" title=\"BioNxt\u2019s BNT23001 for MS enters final animal test before human trials\" rel=\"nofollow\"><img loading=\"lazy\" decoding=\"async\" width=\"800\" height=\"400\" src=\"https:\/\/multiplesclerosisnewstoday.com\/wp-content\/uploads\/2025\/06\/MiceGroup-800x400.png\" class=\"webfeedsFeaturedVisual wp-post-image\" alt=\"Lab mice are shown huddling together in a group.\" style=\"margin: auto;margin-bottom: 15px;max-width: 100%\" data-wp-pid=\"151162\" \/><\/a><\/p>\n<p>Bionxt Solutions has launched the final animal study needed to prepare for human testing of BNT23001, its sublingual version of cladribine, in people with multiple sclerosis\u00a0(MS). The 15-day dosing optimization [&#8230;]<\/p>\n<p>The post <a href=\"https:\/\/multiplesclerosisnewstoday.com\/news-posts\/2025\/10\/28\/bnt23001-ms-enters-final-animal-test-human-trials\/\">BioNxt\u2019s BNT23001 for MS enters final animal test before human trials<\/a> appeared first on <a href=\"https:\/\/multiplesclerosisnewstoday.com\">Multiple Sclerosis News Today<\/a>.<\/p>\n<p><em>Source: <a href=\"https:\/\/multiplesclerosisnewstoday.com\/news-posts\/2025\/10\/28\/bnt23001-ms-enters-final-animal-test-human-trials\/\" rel=\"nofollow noopener\" target=\"_blank\">multiplesclerosisnewstoday.com<\/a><\/em><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Bionxt Solutions has launched the final animal study needed to prepare for human testing of BNT23001, its sublingual version of cladribine, in people with multiple sclerosis\u00a0(MS). The 15-day dosing optimization [&#8230;] The post BioNxt\u2019s BNT23001 for MS enters final animal test before human trials appeared first on Multiple Sclerosis News Today. Source: multiplesclerosisnewstoday.com<\/p>\n","protected":false},"author":0,"featured_media":721,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[4],"tags":[11,15,9,8,13,14,12,10],"class_list":["post-720","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-multiple-sclerosis-research","tag-brain-repair","tag-marburg-type-ms","tag-ms","tag-multiple-sclerosis","tag-myelin","tag-neuroregeneration","tag-oligodendrocyte","tag-remyelination"],"_links":{"self":[{"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/posts\/720","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/comments?post=720"}],"version-history":[{"count":0,"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/posts\/720\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/media\/721"}],"wp:attachment":[{"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/media?parent=720"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/categories?post=720"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/tags?post=720"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}